Aclaris Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Aclaris Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 5% to $31,249,000. Profit margin reached -283%. Total operating expenses were $12,141,000.
Profit Margin
| 2014 | 0 | -10.57M | |
|---|---|---|---|
| 2015 | 0 | -20.56M | |
| 2016 | 0 | -48.07M | |
| 2017 | 1.68M | -68.52M | -4071.48% |
| 2018 | 6.15M | -82.10M | -1334.81% |
| 2019 | 4.22M | -161.35M | -3817.22% |
| 2020 | 6.48M | -51.01M | -787.03% |
| 2021 | 6.76M | -90.86M | -1343.96% |
| 2022 | 29.75M | -86.90M | -292.11% |
| 2023 | 31.24M | -88.48M | -283.15% |
0H8T.L Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 31.24M | 29.75M | 6.76M | 6.48M | 4.22M | 6.15M | 1.68M | 0 | 0 | 0 |
Cost of revenue | 116.46M | 11.96M | 4.71M | 5.13M | 4.05M | 63.51M | 1.20M | 0 | 90K | 0 |
Gross profit | -85.21M | 17.79M | 2.04M | 1.34M | 172.00K | -57.36M | 476K | 0 | -90K | 0 |
Operating exp. | ||||||||||
Research and development | 105.01M | 77.81M | 43.81M | 29.33M | 63.78M | 60.84M | 39.79M | 33.47M | 14.96M | 6.50M |
Selling and marketing | 0 | 0 | 0 | 0 | -607K | 0 | 85K | 3.29M | 0 | 65.99K |
Total operating expenses | 12.14M | 102.94M | 67.43M | 49.86M | 91.00M | 24.74M | 72.29M | 48.07M | 20.28M | 8.53M |
Operating income | -97.35M | -85.15M | -65.38M | -48.51M | -90.83M | -83.12M | -71.82M | -48.35M | -20.37M | -8.53M |
Other income (expenses), net | 8.50M | -1.75M | -25.48M | -2.81M | -22.71M | 1.01M | 1.47M | 272K | -185K | 16K |
Income before tax | -88.84M | -86.90M | -90.86M | -51.33M | -113.54M | -82.10M | -70.35M | -48.07M | -20.56M | -8.51M |
Income tax expense | -367K | 0 | 0 | -182K | 47.81M | 0 | -1.83M | 0 | 2.56M | 2.05M |
Net income | -88.48M | -86.90M | -90.86M | -51.01M | -161.35M | -82.10M | -68.52M | -48.07M | -20.56M | -10.57M |
Earnings per share | ||||||||||
Basic EPS | -1.27 | -1.33 | -1.6 | -1.2 | -3.9 | -2.49 | -2.44 | -2.25 | -3.37 | -6.15 |
Diluted EPS | -1.27 | -1.33 | -1.6 | -1.2 | -3.9 | -2.49 | -2.44 | -2.25 | -3.37 | -6.15 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |